Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
3.850
-0.330 (-7.89%)
At close: May 14, 2025, 4:00 PM
3.840
-0.010 (-0.26%)
After-hours: May 14, 2025, 7:46 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $2.82 million as of May 14, 2025. Its market cap has decreased by -42.88% in one year.
Market Cap
2.82M
Enterprise Value
-535.87K
1-Year Change
-42.88%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $2.82M, a decrease of -99.75%. That is a compound annual growth rate of -78.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 3.06M | -51.38% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 654.81B |
| Johnson & Johnson | 352.73B |
| AbbVie | 322.33B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 286.29B |
| Abbott Laboratories | 224.82B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |